- Home
- AIRS vs CHEC Comparison
AIRS vs CHEC Comparison
Compare AIRS & CHEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIRS | CHEC |
|---|---|---|
| Founded | 2012 | 2024 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.4M | 175.5M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | AIRS | CHEC |
|---|---|---|
| Price | $1.65 | $10.27 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 859.3K | 10.9K |
| Earning Date | 11-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $151,818,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.65 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.51 | $9.91 |
| 52 Week High | $12.00 | $10.56 |
Technical Indicators
Market Signals| Indicator | AIRS | CHEC |
|---|---|---|
| Relative Strength Index (RSI) | 30.98 | 57.14 |
| Support Level | $1.57 | $10.22 |
| Resistance Level | $2.03 | $10.30 |
| Average True Range (ATR) | 0.14 | 0.01 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 8.69 | 57.14 |
Price Performance
Historical ComparisonAbout AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
About CHEC Chenghe Acquisition III Co. Class A Ordinary Share
Chenghe Acquisition III Co is blank check company.